Exploring New Technologies For Glaucoma Clinical Drug Trials ~ 2010-01-28

The Citizen Eye Institute (NEI) and the Foodstuffs and Pharmaceutical Administration (FDA) sponsored a symposium to consider stylish disease-relevant outcome measures appropriate seeing that evaluating glaucoma therapies.

Currently, clinical knock out trials pro glaucoma therapies rely on rule perimetric criteria - i.e., a delusion field try out - as the primary functional outcome measure.

Come what may, new technologies that assess abnormalities and changes in the optic nerve construct and its act extend foresight researchers additional pathways to better diagnose and care of glaucoma.

This symposium choose focus on new effect measures appropriate for the sake of ranking of glaucoma therapies. The goal is to hearten the development of restored glaucoma therapies, facilitate their evaluation and ultimately benefit patients.

Attendees included:

* Clinical researchers/basic scientists

* Clinical trialists

* Pharmaceutical company representatives

* Legal/advocacy firms

* Associations

* Biotech companies

Glaucoma facts

Glaucoma - a potentially blinding but treatable group of diseases - affects 2.2 million Americans length of existence 40 and older, resulting in direct medical costs of $2.86 billion annually.

* Glaucoma robs individuals of peripheral and eventually median hallucination.

* Glaucoma is a complex group of neurodegenerative diseases that arises from ongoing damage to the optic nerve and retinal ganglion cells and their axons.

* It is harmonious of the four major aging eye diseases, alongside era-interconnected macular degeneration, diabetic retinopathy and cataracts.

* About 50 percent of sufferers are unaware they demand the disease.

* Glaucoma disproportionately affects minority populations: It is three times more common in African Americans than in whites and is the leading cause of irreversible dream shrinkage in African Americans and Hispanics.

* There is a extensive prominent health weight from glaucoma justified to decreased productivity, reduced independence and diminished quality of life.

—————————-
Article adapted by Medical News Today from underived seethe release.
—————————-

Beginning: Lancey Cowan

Association for the benefit of Research in Vision and Ophthalmology